Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CNS
CNS
New Meds Set to Reshape US CNS and oncology Markets
Xconomy
Tue, 02/18/20 - 08:36 pm
CNS
oncology
cancer
Clarivate Analytics
Biohaven
rimegepant
Novartis
OMB-157
Alkermes To Acquire Rodin Therapeutics
NASDAQ
Mon, 11/18/19 - 09:58 am
Alkermes
Rodin Therapeutics
M&A
CNS
Sarepta pays StrideBio $48M for preclinical gene therapies
Fierce Biotech
Fri, 11/15/19 - 11:09 am
Sarepta Therapeutics
StrideBio
gene therapies
CNS
Nektar Therapeutics launches Inheris Biopharma
Pharmaceutical Business Review
Fri, 05/24/19 - 10:37 am
Nektar Therapeutics
Inheris Biopharma
CNS
Pair of deals boosts Biogen’s early-stage CNS pipeline
Pharmaforum
Mon, 01/7/19 - 11:20 am
Biogen
CNS
Alzheimer's disease
MS
C4 Therapeutics
Skyhawk Therapeutics
Lundbeck Partners with AI Driven Numerate to Tackle Central Nervous System Disorders
CP Wire
Mon, 01/7/19 - 10:14 am
Lundbeck
Numerate
artificial intelligence
CNS
Bain Capital and Pfizer Create New Company Focused on CNS Disorders
CP Wire
Tue, 10/23/18 - 01:57 pm
Bain Capital
Pfizer
Cerevel Therapeutics
CNS
Neurocrine, Jnana team up to discover CNS drugs
Fierce Biotech
Wed, 10/10/18 - 10:17 am
Neurocrine Biosciences
Jnana Therapeutics
small molecule drugs
CNS
drug discovery
Sarepta all-in on gene therapy pipeline, adding 3 CNS treatments in $30M Lacerta deal
Endpoints
Wed, 08/8/18 - 10:42 pm
Sarepta Therapeutics
CNS
Pompe disease
Lacerta
Takeda surfs a potential $2B Wave of acquisitions
Biopharma Dive
Wed, 02/21/18 - 11:04 am
Takeda
M&A
Wave Life Sciences Ltd
drug development
CNS
Boehringer Ingelheim inks CNS deal with Autifony
BioPharma Dive
Tue, 12/19/17 - 11:59 am
Boehringer Ingelheim
Autifony
CNS
The Little-Known Reason Arena Pharmaceuticals Could Be a Winner
Motley Fool
Wed, 06/1/16 - 04:49 pm
Arena Pharmaceuticals
Belviq
CNS
Boehringer Ingelheim
Allergan beefs up its CNS portfolio ahead of Pfizer merger
BioPharma Dive
Tue, 12/1/15 - 02:15 pm
Allergan
Pfizer
M&A
CNS
Rugen Therapeutics
Macrophage Therapeutics to Expand Efforts Into CNS Diseases
Yahoo
Sat, 03/21/15 - 10:43 am
Macrophage Therapeutics
CNS
One big reason why CNS drug development has foundered
Fierce Biotech
Thu, 01/29/15 - 11:34 am
CNS
R&D
Parkinson's Disease
Sage soars after banking $90M in an up-sized IPO
Fierce Biotech
Fri, 07/18/14 - 11:20 am
SAGE Therapeutics
CNS
IPOs
IPO Preview: Minerva Neurosciences
Seeking Alpha
Thu, 06/26/14 - 09:38 am
Minerva Neurosciences
IPOs
CNS
The hottest disease field for biotech startups and M&A might surprise you
Fierce Biotech
Fri, 08/16/13 - 09:25 am
biotech
start-ups
M&A
CNS
Teva Focuses on Central Nervous System, Respiratory Drugs
Bloomberg
Wed, 12/12/12 - 08:05 am
CNS
Respiratory
Teva
Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
Yahoo
Thu, 09/6/12 - 10:28 am
Neuralstem
stem cells
CNS
ALS
Lou Gehrig's disease
Pages
« first
‹ previous
1
2
3
next ›
last »